Dexmedetomidine — Comprehensive Overview

1. Mechanism of Action

• Sedation/hypnosis: via α₂ receptors in the locus coeruleus → activates endogenous sleep pathways, producing a state resembling physiologic NREM sleep
• Analgesia: via α₂ receptors at the spinal cord level (dorsal horn)
• Sympatholysis: reduces central noradrenergic outflow → decreased heart rate, BP, and plasma catecholamines
• Its effects are reversible with α₂-antagonists (e.g., atipamezole)

2. Pharmacokinetics

3. Organ System Effects

CNS

• Sedation resembling natural sleep — patients are arousable and cooperative
• Anxiolysis, mild analgesia
• Minimal amnesia (vs. benzodiazepines)
• ↓ cerebral blood flow (CBF ~25%), without significant change in ICP or CMRO₂
• Potential for tolerance and dependence with prolonged use
• Anti-shivering properties (via α₂ activation in thermoregulatory center)

Cardiovascular

• Loading bolus: transient ↑ BP (peripheral α₂ vasoconstriction) → followed by ↓ HR (reflex + central vagal predominance)
• Infusion: ↓ HR, ↓ SVR, ↓ BP (moderate)
• Risk of severe bradycardia, heart block, sinus arrest — especially when combined with sympatholytic or vagotonic agents (e.g., neostigmine, β-blockers, digoxin)
• Response to atropine/anticholinergics is preserved

Respiratory

• Minimal respiratory depression — ventilatory response to CO₂ unchanged
• Small ↓ tidal volume, essentially no change in RR
• Upper airway obstruction can occur with deep sedation
• Preserves spontaneous respiration even at high doses (key advantage)
• Synergistic sedation when combined with other sedative-hypnotics

4. Clinical Uses

ICU Sedation (Primary Indication)

• First-line for short-term sedation of intubated/ventilated ICU patients
• Advantages over benzodiazepines:
  • ↓ duration of mechanical ventilation
  • ↑ patient comfort
  • ↓ incidence and duration of perioperative delirium
  • More cooperative behavior ("cooperative sedation")

Monitored Anesthesia Care (MAC) / Procedural Sedation

• Useful for awake fiberoptic intubation — cooperative, comfortable patient + dry mouth effect
• Painful procedures — analgesic properties supplement sedation
• Lower legislative restrictions vs. propofol in some jurisdictions

Adjunct to General Anesthesia

• Reduces requirements for inhaled and IV anesthetics
• Dose: 0.5–1 mcg/kg loading over 10–15 min → infusion 0.2–0.7 mcg/kg/h
• Preoperative dexmedetomidine reduces fentanyl consumption in abdominal, cholecystectomy, and intraocular surgery
• Smooth emergence; sedative + analgesic effects persist into PACU without respiratory depression

Pediatrics (off-label)

• Intranasal dexmedetomidine 1 mcg/kg — preoperative anxiolysis
• ICU sedation in children
• Arousability preserved; sedation resembles natural sleep

Regional Anesthesia Adjunct

• Perineural injection as adjunct to brachial plexus block — may extend duration (evidence limited, not statistically significant in all studies)

5. Dosing

6. Adverse Effects & Contraindications

• Hypotension — most common; can persist for hours (limits PACU discharge)
• Bradycardia / Heart block / Sinus arrest — especially with vagotonic co-medications
• Transient hypertension with rapid bolus
• Dry mouth
• Tolerance/dependence with prolonged infusion

• Sympatholytic agents (β-blockers, clonidine)
• Cholinergic agents (neostigmine, physostigmine)
• Other sedatives (synergistic respiratory depression risk)

• Advanced heart block or sick sinus syndrome (without pacemaker)
• Severe hepatic impairment (↓ clearance)
• Renal impairment (↑ duration of effect)
• Hypovolemia

7. Dexmedetomidine in Muscular Dystrophy (MD) Context

• Avoids triggering malignant hyperthermia — unlike volatile agents and succinylcholine, which are contraindicated in Duchenne/Becker MD
• Preserves respiratory function — critical in patients with MD-related respiratory muscle weakness
• Cardiac safety: MD patients often have cardiomyopathy — dexmedetomidine's sympatholytic effect reduces myocardial oxygen demand, but its bradycardia risk requires careful monitoring
• One published case (PMID 38855294, 2024) describes combined general + regional anesthesia in a Duchenne MD patient with LVAD undergoing orthopedic surgery, where careful agent selection (avoiding triggers) was essential

Summary

Double-Lumen Endotracheal Tube (DLT)

1. Design & Structure

• Tracheal cuff — proximal, seals the trachea
• Bronchial cuff (typically colored blue) — distal, seals the intubated bronchus

• Left-sided DLT — bronchial lumen goes into the left mainstem bronchus (preferred for most cases)
• Right-sided DLT — bronchial lumen goes into the right mainstem bronchus; has a ventilation slot to preserve right upper lobe (RUL) ventilation

Left and right Robertshaw tubes with their correct positions at the carina — Murray & Nadel's Respiratory Medicine

Correct position of left- (left) and right-sided (right) DLT — Morgan & Mikhail's Clinical Anesthesiology

2. Indications

Absolute Indications (lung isolation mandatory)

• Protection of the healthy lung from contamination (e.g., massive hemoptysis, lung abscess, empyema, bronchopleural fistula)
• Unilateral pulmonary lavage (e.g., pulmonary alveolar proteinosis)
• Large bronchopleural or bronchopleural-cutaneous fistula
• Life-threatening hemorrhage from one lung

Relative Indications (surgical access)

• Thoracic aortic aneurysm repair
• Pneumonectomy, lobectomy, segmentectomy
• Esophageal surgery
• Thoracoscopy (VATS)
• Bilateral sympathectomy / bilateral procedures requiring independent lung ventilation
• Single lung transplantation

3. Left vs. Right DLT — Which to Use?

Indications for a Right-Sided DLT

4. Size Selection

5. Insertion Technique

1. Laryngoscopy — MacIntosh (curved) blade preferred; provides more room to maneuver the large tube. Video laryngoscopy is also acceptable.
2. Pass the DLT with the distal curvature concave anteriorly.
3. Once the bronchial cuff clears the vocal cords, rotate 90° toward the target bronchus (counterclockwise for left-sided placement).
4. Advance until resistance is felt (average depth ~29 cm at teeth) or advance over a fiberoptic bronchoscope placed through the bronchial lumen.
5. Do not force — the cricoid ring diameter approximates the left mainstem bronchus diameter and is the narrowest point.

6. Confirming Position — Clinical Protocol (Left-Sided DLT)

1. Inflate tracheal cuff (5–10 mL) → check for bilateral breath sounds
   • Unilateral = tube too far down
2. Inflate bronchial cuff (1–2 mL)
3. Clamp tracheal lumen → ventilate via bronchial lumen
   • Should hear left-sided only breath sounds
   • If right-sided sounds persist → bronchial opening still in trachea → advance tube
   • If right-sided only → tube in right bronchus → reposition
   • If left upper lobe silent → tube too far down left bronchus → withdraw
4. Unclamp tracheal, clamp bronchial lumen → ventilate via tracheal lumen
   • Should hear right-sided breath sounds
   • Absent/diminished = bronchial cuff occluding distal trachea → withdraw

• Through tracheal lumen: carina visible; bronchial lumen entering left bronchus; blue bronchial cuff 5–10 mm below carina in left bronchus, not herniating over carina
• Through bronchial lumen: patent; left upper and lower lobe orifices visible

FOB view down the tracheal lumen: bronchial tube seen entering left bronchus, carina visible, bronchial cuff just below carina — Morgan & Mikhail

• Through right-sided DLT bronchial lumen: confirm RUL ventilation slot aligns with RUL orifice
• Re-confirm position after repositioning patient to lateral decubitus (tube can migrate)

7. Malposition Problems (6 Types)

8. DLT vs. Bronchial Blocker (BB) — Comparison

9. One-Lung Ventilation (OLV) After DLT Placement

• Patient in lateral decubitus — operative ("up") lung isolated/collapsed; ventilated ("down") lung is dependent
• Start with FiO₂ 1.0 during OLV for safety margin
• Tidal volume: 5–6 mL/kg (lung-protective)
• Apply PEEP 5 cmH₂O to dependent lung
• If hypoxemia: apply CPAP 5–10 cmH₂O to non-dependent lung, or recruit dependent lung